Fetal cell isolation and characterization for cell-based non-invasive prenatal genetic diagnosis

Size-exclusion micro-fluidic technology will be developped to capture fetal trophoblasts from maternal peripheral blood, allowing downstream massively parallel sequencing analyses. These methods can be used to develop non-invasive prenatal testing (NIPT) providing diagnoses that can currently only be obtained by invasive techniques.